Healthcare provider profile · identity verified

Shane Robert Yarrington, DO

Family Practice · ASPERS, PA · NPI 1740710078

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	445	138
Lisinopril	Lisinopril	323	101
Amlodipine Besylate	Amlodipine Besylate	246	75
Rosuvastatin Calcium	Rosuvastatin Calcium	241	67
Omeprazole	Omeprazole	236	66
Metoprolol Succinate	Metoprolol Succinate	225	82
Pantoprazole Sodium	Pantoprazole Sodium	190	43
Gabapentin	Gabapentin	182	48
Tamsulosin Hcl	Tamsulosin Hcl	181	59
Fluticasone Propionate	Fluticasone Propionate	156	70
Losartan Potassium	Losartan Potassium	156	44
Levothyroxine Sodium	Levothyroxine Sodium	135	35
Eliquis	Apixaban	128	35
Furosemide	Furosemide	125	37
Simvastatin	Simvastatin	120	36
Sertraline Hcl	Sertraline Hcl	112	27
Clopidogrel	Clopidogrel Bisulfate	96	24
Trazodone Hcl	Trazodone Hcl	96	31
Metformin Hcl	Metformin Hcl	90	35
Escitalopram Oxalate	Escitalopram Oxalate	89	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	88	26
Metoprolol Tartrate	Metoprolol Tartrate	85	29
Hydrochlorothiazide	Hydrochlorothiazide	84	25
Pravastatin Sodium	Pravastatin Sodium	83	25
Albuterol Sulfate Hfa	Albuterol Sulfate	79	26
Metformin Hcl Er	Metformin Hcl	79	20
Glimepiride	Glimepiride	71	29
Allopurinol	Allopurinol	69	22
Tramadol Hcl	Tramadol Hcl	69	16
Fluoxetine Hcl	Fluoxetine Hcl	66	16
Carvedilol	Carvedilol	65	19
Finasteride	Finasteride	64	20
Spironolactone	Spironolactone	64	15
Alprazolam	Alprazolam	61	14
Buspirone Hcl	Buspirone Hcl	61	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	17
Pioglitazone Hcl	Pioglitazone Hcl	59	20
Ropinirole Hcl	Ropinirole Hcl	56	13
Venlafaxine Hcl Er	Venlafaxine Hcl	56	12
Ezetimibe	Ezetimibe	54	18
Jardiance	Empagliflozin	54	15
Meloxicam	Meloxicam	54	18
Prednisone	Prednisone	54	48
Lorazepam	Lorazepam	51	21
Diclofenac Sodium	Diclofenac Sodium	47	20
Zolpidem Tartrate	Zolpidem Tartrate	47	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	14
Famotidine	Famotidine	45	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	11
Donepezil Hcl	Donepezil Hcl	43	12
Januvia	Sitagliptin Phosphate	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	40
Duloxetine Hcl	Duloxetine Hcl	41	12
Cephalexin	Cephalexin	39	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	14
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	11
Synthroid	Levothyroxine Sodium	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Chlorthalidone	Chlorthalidone	35	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	15
Bumetanide	Bumetanide	33	11
Doxycycline Hyclate	Doxycycline Hyclate	33	30
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	11
Baclofen	Baclofen	32	13
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Lactulose	Lactulose	32	suppressed
Montelukast Sodium	Montelukast Sodium	32	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	23
Ibuprofen	Ibuprofen	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	16
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Atenolol	Atenolol	22	suppressed
Methylprednisolone	Methylprednisolone	22	22
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Naproxen	Naproxen	21	suppressed
Valsartan	Valsartan	21	suppressed
Telmisartan	Telmisartan	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Glipizide	Glipizide	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Azithromycin	Azithromycin	16	15
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Fluconazole	Fluconazole	16	11
Ozempic	Semaglutide	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Nystatin	Nystatin	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sucralfate	Sucralfate	13	suppressed
Topiramate	Topiramate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nystop	Nystatin	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Praluent Pen	Alirocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error